ArticleJournal for immunotherapy of cancer2023

Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda

Lena Immisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.